iSpecimen Inc (ISPC) support and resistance · rev $9.3M
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
This page maps iSpecimen Inc (ISPC) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
ISPC currently screens at market cap $4.4M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ISPC 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ISPC quote page for the session range and the stock page for the full model.
Not investment advice.